Previous 10 | Next 10 |
iBio (IBIO) is up 2% premarket, after regaining compliance with NYSE American continued listing standards.By meeting the requirements of the $50M market capitalization, the company has resolved its continued listing deficiency with NYSE. For further details see: iBio regains c...
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that on October 1, 2020, the Company received written notice from the NYS...
Bristol Myers Squibb receives FDA approval for immunotherapy combo. iBio inks deal with Safi Biosolutions for harnessing FastPharming System. Otonomy reports completing patient recruitment for Otividex trial. For further details see: Bristol Myers Squibb's Newest Immunot...
IBio (IBIO) jumps 10% premarket after entering into a Master Services Agreement with Boston-based Safi Biosolutions to evaluate its FastPharming System for the expression of key proteins to be used in the bioprocessing of Safi blood cell therapy products. The company plans to g...
- Project Focused on Proteins used in the Production of Blood Cells - NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced...
Dr. Anthony Fauci took to Facebook Live on Thursday to assuage increasing concerns about a politicized approval process for a potential coronavirus vaccine."People are always saying, 'How do I know it’s safe? How do I know it's effective? There's a lot of confusion because there are mi...
FinancialBuzz.com News Commentary New York, NY (9/24/2020) – The pandemic has drastically reshaped the global social and economic landscape. Countries have shut down schools and businesses, restricted travel, postponed entertainment and sporting events, and are still encouraging ...
Reports on Tuesday suggested the FDA was considering stricter guidelines for emergency-use authorization of a coronavirus vaccine, though the White House may not approve of them."It sounds like a political move," President Trump said at a press conference. "When you have Pfizer (PFE), Johnson...
Are These On Your List Of Penny Stocks To Buy This Week? Have you made your list of penny stocks this week? If you haven’t and are just getting things started, you’ve got your work cut out. There’ve been a lot of discussions over the weekend on what to focus on this week...
Traders on the Robinhood investing app are notorious for picking highly speculative stocks -- and as a group, they're too powerful to ignore if you're considering an investment in smaller biotech companies. Especially in the context of hot equities with millionaire-maker potential, hopping on th...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...